J&J Archives -

Articles/ Oncology/ R&D/ R&D/ Sales and Marketing/ US/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

A history of Johnson & Johnson

Claire A history of..., Alex Gorsky, J&J, Janssen, Johnson & Johnson, Paul Janssen 0 Comment

Set up by three brothers back in 1886, Johnson & Johnson continues to keep evolving

A history of Johnson & Johnson

https://pharmaphorum.com/views-analysis-sales-marketing/a-history-of-johnson-johnson/

Janssen J&J Johnson and Johnson pharmaceutical companies

Market Access/ News/ News

J&J asks FDA for emergency clearance for single-shot COVID-19 vaccine

Richard Staines COVID-19, infectious diseases, J&J, R&D, vaccine 0 Comment

Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for

J&J asks FDA for emergency clearance for single-shot COVID-19 vaccine

https://pharmaphorum.com/news/jj-asks-fda-for-emergency-clearance-for-single-shot-covid-19-vaccine/

Podcast/ R&D/ Views & Analysis/ Views and analysis

J&J and medical device innovation: the pharmaphorum podcast

Dominic Tyer J&J, medical devices, podcast 0 Comment

In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU regional vice president at

J&J and medical device innovation: the pharmaphorum podcast

https://pharmaphorum.com/r-d/johnson-medical-device-innovation-podcast/

Oncology/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

The top 5 pharma M&A deals of 2020

George Underwood Gilead, J&J, Johnson and Johnson, M&A, Merck & Co, MSD, Sanofi 0 Comment

2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout

The top 5 pharma M&A deals of 2020

https://pharmaphorum.com/views-and-analysis/the-top-5-pharma-ma-deals-of-2020/

Market Access/ News/ News/ News/ Oncology

Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission

George Underwood Darzalex, Darzalex Faspro, Imnovid, J&J, Janssen, Johnson, multiple myeloma 0 Comment

Janssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for approval with the

Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission

https://pharmaphorum.com/news/janssen-combines-darzalex-with-covid-drug-in-new-multiple-myeloma-submission/

Market Access/ News/ News

Canada signs deals for J&J, Novavax COVID vaccines

George Underwood Canada, coronavirus, coronavirus vaccine, COVID-19, COVID-19 vaccine, J&J, Janssen, Novavax 0 Comment

The Canadian government has reached agreements in principle with J&J and Novavax to buy their coronavirus vaccine candidates.

Canada signs deals for J&J, Novavax COVID vaccines

https://pharmaphorum.com/news/canada-signs-deals-for-jj-novavax-covid-vaccines/

Digital/ Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Rebooting the healthcare system post-COVID-19

mike.hammerton@pharmaphorum.com coronavirus, COVID-19, J&J, Janssen 0 Comment

Janssen’s Iris Zemzoum looks at seven ways the healthcare and pharma sectors need to change in the wake

Rebooting the healthcare system post-COVID-19

https://pharmaphorum.com/views-analysis-digital/rebooting-the-healthcare-system-post-covid-19/

Digital/ Video/ Views & Analysis/ Views and analysis

Investing in innovation – new digital approaches for a new decade

mike.hammerton@pharmaphorum.com BIO-Europe Spring, J&J, J&J Innovation, Janssen 0 Comment

For the first time in history, we have the technologies that will allow us to develop new

Investing in innovation – new digital approaches for a new decade

https://pharmaphorum.com/views-analysis-digital/investing-in-innovation-new-digital-approaches-for-a-new-decade/

R&D/ Views & Analysis/ Views and analysis

Janssen’s Gaëtan Leblay on leading during the COVID-19 crisis

Paul Tunnah coronavirus, COVID-19, J&J, Janssen, UK Leaders 0 Comment

COVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic.

Janssen’s Gaëtan Leblay on leading during the COVID-19 crisis

https://pharmaphorum.com/r-d/views-analysis-r-d/janssens-gaetan-leblay-on-leading-during-the-covid-19-crisis/

Trending

J&J

Login